The Menopause Support Gap: What the Workplace Data Shows

Menopause is a normal health transition that most women go through — and yet the support around it, at work and in healthcare, is so thin that many women change or leave their jobs rather than get help. The data turns a private experience into a measurable economic and health-system failure.

This happens, for most women, at the height of their working lives: often at the peak of their experience, their earning power and their seniority, frequently while raising teenagers or caring for ageing parents. The average age of menopause in the UK is around 51, though symptoms often begin years earlier in perimenopause. Menopause arrives in the middle of all of it — the broken sleep, the sudden heat that floods a meeting, the brain fog that makes a familiar task feel unfamiliar, the anxiety that was never there before. None of it is a failure of character. But without support around it, women are quietly worn down and, too often, worn out of the workforce altogether. The figures below are the shape of that loss.

The workplace cost

A landmark survey of 4,000 women aged 45–55 by the Fawcett Society and Channel 4 found that 1 in 10 had left a job because of menopause symptoms — equivalent to around 333,000 women across the UK. Many more scaled back.

Read these figures as an escalation and you can trace a slow withdrawal. First a woman decides not to put herself forward for the promotion she has earned. Then she drops her hours to cope. Then, for one in ten, she leaves altogether. Each step is framed as a personal choice, but almost none of it would be necessary with basic adjustments — a fan, a quiet space, a manager who understands, flexibility on the worst days. What the data captures is not women opting out; it is women being edged out, one unmet need at a time.

That single figure explains much of the rest. When four in five workplaces offer nothing — no information, no trained managers, no policy — a woman experiencing symptoms is left to improvise a solution alone, usually in silence, and often while worrying that asking will make her look less capable. The absence of support is not neutral. It sends a message that this stage of life is a private embarrassment to be hidden rather than an ordinary health transition to be accommodated, and it pushes the cost squarely onto the women themselves.

A support gap, not a lack of resilience

The same study found that two in five women who took time off for menopause recorded anxiety or depression on their sick note rather than name the menopause — a sign of how little space there is to discuss it. The pattern points to missing provision, in workplaces and in healthcare, rather than women failing to cope with a normal life stage.

Think about what that concealment costs. A woman writes "anxiety" on a form because she does not trust that "menopause" will be met with understanding — and in doing so she disappears from the record. Her symptoms go uncounted, her real needs go unaddressed, and the next woman inherits the same silence. It is a self-reinforcing gap: the less menopause is named, the less it is planned for, and the harder it becomes to name. Breaking that cycle does not require women to be more resilient. It requires the systems around them — HR policies, line managers, GPs and specialist services — to make it safe and normal to say the word out loud.

When those barriers ease even slightly, the scale of the unmet need becomes visible. As awareness has grown and the cost of a prescription has come down, demand for treatment has surged: the number of HRT items dispensed in England reached 11 million in 2022–23, prescribed to 2.3 million people — a 47% jump in a single year. A rise that steep is not a passing fashion. It is years of women who were quietly going without, finally getting help the moment it became a little easier to ask for — which tells you how many were managing alone before.

What this means day to day

The lived reality behind these percentages is relentless and cumulative. It is lying awake at 3am for the third night running and then facing a full day's work; it is losing a word mid-sentence in front of colleagues and feeling competence quietly slip; it is the flush that arrives, uninvited, in the moment you most need to be composed. Managed well — with the right information, the right workplace adjustments and, where appropriate, the right clinical care — these symptoms are navigable, and most women carry on thriving in their careers. Managed by pretending they are not happening, they compound until something gives. The difference between those two outcomes is not the woman. It is whether anyone built support around her.

How to read this data

The workplace figures are from the Fawcett Society / Channel 4 survey of 4,000 UK women aged 45–55; the 333,000 figure is an extrapolation to the UK population of that age group. The HRT dispensing figures (11 million items in 2022–23 to 2.3 million patients, up 47% in a year) are from NHS Business Services Authority statistics; the "6 in 10" work-impact figure is from NHS England's menopause guidance (citing CIPD, 2022); and the average age of menopause (~51) is from the NHS. This is analysis of published data, not new research.

Why we're publishing this

Better Health For Everyone is a commercial UK health-insurance resource, not a charity or a campaign. We pulled this evidence together because the people arguing for better menopause support — in workplaces, in Parliament, in the health service — are strongest when the scale of the problem is set out plainly and can be cited without hunting for the source. We are not claiming the cause as our own; we are amplifying the voices of the women and organisations who have carried it, and putting the numbers at their disposal.

Free to cite with attribution to Better Health For Everyone — for policy submissions, employer briefings, campaigns and reporting. For the figures or a bespoke chart in your organisation's style, get in touch.